These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19531590)

  • 1. Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?
    Van den Berghe G; Schetz M; Vlasselaers D; Hermans G; Wilmer A; Bouillon R; Mesotten D
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3163-70. PubMed ID: 19531590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood glucose control in the intensive care unit: benefits and risks.
    Gunst J; Van den Berghe G
    Semin Dial; 2010; 23(2):157-62. PubMed ID: 20525106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefits of tight glycaemic control: focus on the intensive care unit.
    Mesotten D; Van den Berghe G
    Best Pract Res Clin Anaesthesiol; 2009 Dec; 23(4):421-9. PubMed ID: 20108581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR)--a review of recent literature.
    Scurlock C; Raikhelkar J; Mechanick JI
    Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):211-4. PubMed ID: 20010098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in outcome between the NICE-SUGAR and Leuven trials: biological mechanisms of intensive glucose control in critically ill patients.
    Myburgh JA; Chittock DR
    Crit Care Resusc; 2009 Sep; 11(3):178-9. PubMed ID: 19737118
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in outcome between the NICE-SUGAR and Leuven trials: possible methodological explanations.
    Henderson WR; Finfer S
    Crit Care Resusc; 2009 Sep; 11(3):175-7. PubMed ID: 19737117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Glycaemia control in critically ill patients is justified and effective].
    Rybka J
    Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.
    Meyfroidt G; Keenan DM; Wang X; Wouters PJ; Veldhuis JD; Van den Berghe G
    Crit Care Med; 2010 Apr; 38(4):1021-9. PubMed ID: 20124887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication and practical use of intensive insulin therapy in the critically ill.
    Mebis L; Gunst J; Langouche L; Vanhorebeek I; Van den Berghe G
    Curr Opin Crit Care; 2007 Aug; 13(4):392-8. PubMed ID: 17599008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.
    Van den Berghe G; Wouters PJ; Bouillon R; Weekers F; Verwaest C; Schetz M; Vlasselaers D; Ferdinande P; Lauwers P
    Crit Care Med; 2003 Feb; 31(2):359-66. PubMed ID: 12576937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lowering of glucose in critical care: a randomized pilot trial.
    McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
    J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus recommendations for the management of hyperglycaemia in critically ill patients in the Indian setting.
    Mukherjee JJ; Chatterjee PS; Saikia M; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):16-25. PubMed ID: 25668933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose control in the intensive care unit: a nutrition support perspective.
    Krenitsky J
    Nutr Clin Pract; 2011 Feb; 26(1):31-43. PubMed ID: 21266695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stress hyperglycemia and its control with insulin in critically ill patients: current evidence].
    Manzanares W; Aramendi I
    Med Intensiva; 2010 May; 34(4):273-81. PubMed ID: 19944490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How low should you go? The limbo of glycemic control in intensive care units.
    Faust AC; Attridge RL; Ryan L
    Crit Care Nurse; 2011 Aug; 31(4):e9-e18. PubMed ID: 21807674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tight blood glucose control: what is the evidence?
    Vanhorebeek I; Langouche L; Van den Berghe G
    Crit Care Med; 2007 Sep; 35(9 Suppl):S496-502. PubMed ID: 17713399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy in high-risk cardiac surgery patients: evidence from the Leuven randomized study.
    Vanhorebeek I; Ingels C; Van den Berghe G
    Semin Thorac Cardiovasc Surg; 2006; 18(4):309-16. PubMed ID: 17395027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tight blood glucose control with insulin in the ICU: facts and controversies.
    Vanhorebeek I; Langouche L; Van den Berghe G
    Chest; 2007 Jul; 132(1):268-78. PubMed ID: 17625087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoption and implementation of the original strict glycemic control guideline is feasible and safe in adult critically ill patients.
    Schultz MJ; Harmsen RE; Korevaar JC; Abu-Hanna A; Van Braam Houckgeest F; Van Der Sluijs JP; Spronk PE
    Minerva Anestesiol; 2012 Sep; 78(9):982-95. PubMed ID: 22531562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.